整合素连接激酶在重组结缔组织生长因子诱导大鼠肝星状细胞表型转化中的作用

李光明; 颜士岩; 王军; 潘勤; 范建高

doi:10.3969/j.issn.1001-5256.2014.02.015

整合素连接激酶在重组结缔组织生长因子诱导大鼠肝星状细胞表型转化中的作用

DOI: 10.3969/j.issn.1001-5256.2014.02.015

上海交通大学附属新华医院消化科

基金项目:

国家自然科学基金(81070344/81071888)；中国肝炎基金会王宝恩肝纤维化研究基金(20090007)；

详细信息

中图分类号: R575.2
计量
- 文章访问数: 2937
- HTML全文浏览量: 14
- PDF下载量: 597
- 被引次数: 0
出版历程
- 收稿日期: 2013-07-18
- 出版日期: 2014-02-20

Role of integrin- linked kinase in phenotypic transformation of rat hepatic stellate cells induced by recombinant connective tissue growth factor

Department of Gastroenterology, Xinhua Hospital, Shanghai Jiaotong University School of Medicine

Research funding:

摘要

摘要:
目的研究整合素连接激酶（ILK）在重组结缔组织生长因子（rCTGF）诱导大鼠原代肝星状细胞（HSC）表型转化中的作用。方法应用胶原酶原位灌注+密度梯度离心法分离SD大鼠原代HSC,细胞贴壁培养24 h后以rCTGF处理,24 h后转染ILK小干扰RNA（siRNA）或对照siRNA,设rCTGF对照及空白对照。应用RT-PCR及Western Blot检测转染siRNA 24、48及72 h时HSCα平滑肌肌动蛋白（αSMA）、ILK及I型胶原基因表达水平变化。计量资料采用t检验。结果与空白对照相比,rCTGF处理可显著上调大鼠HSCαSMA、ILK蛋白及I型胶原mRNA表达。转染ILK siRNA可特异性抑制rCTGF诱导的ILK表达上调,与rCTGF对照相比,转染ILK siRNA 24、48及72 h时,HSC ILK蛋白表达分别下调72%±6%（t=21.39,P<0.01）、87%±9%（t=68.25,P<0.01）及47%±3%（t=18.25,p=0.003）;αsma蛋白及i型胶原mrna表达分别下调5%±1%（t=2.52,p>0.05）及6%±3...
- 整合素连接激酶 /
- 结缔组织生长因子 /
- 星型细胞 /
- RNA,小分子干扰
Abstract:
Objective To investigate the role of integrin- linked kinase ( ILK) in the phenotypic transformation of rat's primary hepatic stellate cells ( HSCs) induced by recombinant connective tissue growth factor ( rCTGF) . Methods Primary HSCs were isolated from normal Sprague Dawley rats by in situ perfusion of collagenase and density gradient centrifugation. After 24 h of adherent cell culture, HSCs were treated with rCTGF for another 24 h before they were transfected with ILK small interfering RNA ( siRNA) or control siRNA. An rCTGF control group ( HSCs treated with only rCTGF) and a blank control group ( HSCs treated with no rCTGF) were also set up. The gene expression levels of α- smooth muscle actin ( αSMA) , ILK, and type I collagen in HSCs were measured by RT- PCR and Western blot at 24 h, 48 h, and 72 h after transfection with siRNA. The t- test was used for comparisons of measurement data. Results rCTGF significantly upregulated αSMA protein, ILK protein, and type I collagen mRNA in rat HSCs compared with the blank control group. Transfection of rat HSCs with ILK siRNA specifically inhibited the rCTGF- induced ILK upregulation. Compared with those in the rCTGF control group, the expression level of ILK protein in the ILK siRNA- transfected HSCs decreased by 72% ± 6% ( t = 21. 39, P < 0. 01) at 24 h, 87% ± 9% ( t = 68. 25, P < 0. 01) at 48 h, and 47% ± 3% ( t = 18. 25, P = 0. 003) at 72 h; the expression levels of αSMA protein and type I collagen mRNA decreased by 5% ± 1% ( t =2.52, P >0.05) and 6% ±3% ( t =1.63, P >0.05) at 24 h, 31% ±7% ( t =34.77, P <0.01) and 20% ±5% ( t =6.71, P <0.05) at 48 h, and 67% ± 8% ( t = 58. 82, P < 0. 01) and 43% ± 6% ( t = 15. 21, P < 0. 01) at 72 h. No changes were observed in the expression levels of ILK protein, αSMA protein, and type I collagen mRNA in HSCs transfected with control siRNA at the same time points. Conclusion ILK may partly mediate the phenotypic transformation of rat HSCs induced by rCTGF.
- integrin-linked kinase /
- connective tissue growth factor /
- astrocytes /
- RNA, small interfering

HTML全文

参考文献(14)

[1]ZHONG W, XIE WF.New strategy for the treatment of hepatic fibrosis[J].J Clin Hepatol, 2011, 27 (3) :233-235. (in Chinese) 钟巍, 谢渭芬.肝纤维化治疗新策略[J].临床肝胆病杂志, 2011, 27 (3) :233-235.

[2]FRIEDMAN SL.Mechanisms of hepatic fibrogenesis[J].Gastroenterology, 2008, 134 (6) :1655-1669.

[3]CAI WM.Some problems in anti-fibrotic therapies[J].J Clin Hepatol, 2011, 27 (3) :225-232. (in Chinese) 蔡卫民.抗肝纤维化治疗研究的若干问题[J].临床肝胆病杂志, 2011, 27 (3) :225-232.

[4]LIPSON KE, WONG C, TENG Y, et al.CTGF is a central mediator of tissue remodeling and fibrosis and its inhibition can reverse the process of fibrosis[J].Fibrogenesis Tissue Repair, 2012, 5 (Suppl 1) :s24.

[5]HUANG G, BRIGSTOCK DR.Regulation of hepatic stellate cells by connective tissue growth factor[J].Front Biosci, 2012, 1 (17) :2495-2507.

[6]ZHANG Y, IKEGAMI T, HONDA A, et al.Involvement of integrin-linked kinase in carbon tetrachloride-induced hepatic fibrosis in rats[J].Hepatology, 2006, 44 (3) :612-622.

[7]HUANG G, BRIGSTOCK DR.Integrin expression and function in the response of primary culture hepatic stellate cells to connective tissue growth factor (CCN2) [J].J Cell Mol Med, 2011, 15 (5) :1087-1095.

[8]DAI HY, ZHENG M, LYU LL, et al.The roles of connective tissue growth factor and integrin-linked kinase in high glucose-induced phenotypic alterations of podocytes[J].J Cell Biochem, 2012, 113 (1) :293-301.

[9]LI GM, XIE Q, LI DG, et al.RNA interfering connective tissue growth factor prevents rat hepatic stellate cells activation and extracellular matrix production[J].J Gene Med, 2008, 10 (9) :1039-1047.

[10]SATO M, SUZUKI S, SENOO H.Hepatic stellate cells:unique characteristics in cell biology and phenotype[J].Cell Struct Funct, 2003, 28 (2) :105-112.

[11]YANG H, LI XS, XIANG Y, et al.Construction of miRNA expression vector for rat connective tissue growth factor and establishment of stably transfected rat hepatic stellate cell line[J].Chin J Biologicals, 2013, 26 (4) :477-481. (in Chinese) 阳宏, 李孝生, 向颖, 等.大鼠结缔组织生长因子基因miRNA表达质粒的构建及其稳定转染大鼠肝星状细胞系的建立[J].中国生物制品学杂志, 2013, 26 (4) :477-481.

[12]XU SW, ANDREW L, DAVID A.Regulation and function of connective tissue growth factor/CCN2 in tissue repair, scarring and fibrosis[J].Cytokine Growth Factor Rev, 2008, 19 (2) :133-144.

[13]BRIGSTOCK DR.Connective tissue growth factor (CCN2, CTGF) and organ fibrosis:lessons from transgenic animals[J].J Cell Commun Signal, 2010, 4 (1) :1-4.

[14]LIU BC, LI MX, ZHANG JD, et al.Inhibition of integrin-linked kinase via a siRNA expression plasmid attenuates connective tissue growth factor-induced human proximal tubular epithelial cells to mesenchymal transition[J].Am J Nephrol, 2008, 28 (1) :143-151.

施引文献

资源附件(0)

访问统计